To explore the possible mechanism of FGFRL1 resistance in SCLC, we assessed the effect of FGFRL1 on apoptosis and the cell cycle of cell exposure to chemotherapeutic drugs. Here, FGFRL1 is linked to small cell lung carcinoma.